Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis.

Ann Neurol · 2026 · PMC12954145 · PMID 41195640

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Hazard of development of new gadolinium‐enhancing lesions was lower for switchers to infusion DMT, but this did not reach statistical significance for switchers to oral DMTs.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.